Usporiadať podľa
Blood, tissues, cells and organs - Key documents (32)
RSSSummary of the 2022 (2021 data) annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2022 (2021 data) annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2021 (2020 data) annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2021 (2020 data) annual reporting of serious adverse reactions and events for tissues and cells
2022 RAB and RATC annual summary of activity
2022 RAB and RATC annual summary of activity
2021 RAB and RATC annual summary of activity
2021 RAB and RATC annual summary of activity
Summary of the 2020 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2020 annual reporting of serious adverse reactions and events for blood and blood components
2020 RAB and RATC annual summary of activity
2020 RAB and RATC annual summary of activity
Summary of the 2019 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2019 annual reporting of serious adverse reactions and events for blood and blood components
2019 RAB and RATC annual summary of activity
2019 RAB and RATC annual summary of activity
Summary of the 2018 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2018 annual reporting of serious adverse reactions and events for blood and blood components
2018 RAB and RATC annual summary of activity
2018 RAB and RATC annual summary of activity
Summary of the 2017 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2017 annual reporting of serious adverse reactions and events for blood and blood components
2017 RAB and RATC annual summary of activity
2017 RAB and RATC annual summary of activity
Summary of the 2016 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2016 annual reporting of serious adverse reactions and events for blood and blood components
2016 RAB annual summary of activity
2016 RAB annual summary of activity
Summary of the 2015 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2015 annual reporting of serious adverse reactions and events for blood and blood components
2015 RAB annual summary of activity
2015 RAB annual summary of activity
COM(2016) 224 final
COM(2016) 224 final
SWD(2016) 130 final
SWD(2016) 130 final
SWD(2016) 129 final
SWD(2016) 129 final
2014 RAB annual summary of activity
2014 RAB annual summary of activity